Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
FT-002
GENETIC
2 trials
Sponsors
Frontera Therapeutics
Conditions
X-Linked Retinitis Pigmentosa
X-Linked Retinitis Pigmentosa (XLRP)
Early Phase 1
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
Recruiting
NCT05874310
Frontera Therapeutics
X-Linked Retinitis Pigmentosa
Start: 2023-02-01
End: 2027-11-01
Target: 18
Updated: 2023-05-24
Phase 1
Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa
Recruiting
NCT06492850
Frontera Therapeutics
X-Linked Retinitis Pigmentosa (XLRP)
Start: 2024-04-01
End: 2026-02-01
Target: 32
Updated: 2024-07-09
Related Papers
Systematic Identification of Candidate Genes for Inherited Retinal Disease Gene Therapy Integrating Worldwide IRD Cohort and Single-Cell Analysis.
2025-06-12